TY  - GEN
AU  - Lévy,Yves
AU  - Lelièvre,Jean-Daniel
AU  - Assoumou,Lambert
AU  - Aznar,Esther
AU  - Pulido,Federico
AU  - Tambussi,Giuseppe
AU  - Crespo,Manuel
AU  - Meybeck,Agnès
AU  - Molina,Jean-Michel
AU  - Delaugerre,Constance
AU  - Izopet,Jacques
AU  - Peytavin,Gilles
AU  - Cardon,Fanny
AU  - Diallo,Alpha
AU  - Lancar,Rémi
AU  - Béniguel,Lydie
AU  - Costagliola,Dominique
TI  - Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial
SN  - 1539-3704
PY  - 2020///0831
KW  - Adult
KW  - Aged
KW  - Anti-HIV Agents
KW  - administration & dosage
KW  - Antiretroviral Therapy, Highly Active
KW  - methods
KW  - CD4 Lymphocyte Count
KW  - Double-Blind Method
KW  - Female
KW  - HIV Fusion Inhibitors
KW  - HIV Infections
KW  - drug therapy
KW  - HIV-1
KW  - drug effects
KW  - Humans
KW  - Male
KW  - Maraviroc
KW  - Middle Aged
KW  - Treatment Outcome
KW  - Viral Load
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.7326/M19-2133
ER  -